Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | LOX | P28300 | 1/20 | 0.40 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.40 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.34 |
| ▸ | AAK1 | Q2M2I8 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SLC13A5 | Q86YT5 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23216904 | 1.00 | CASP1 (0.40) | CASP1HSD17B10LOXLOXL2SORT1 | |
| SCHEMBL23214882 | 0.92 | LOX (0.38) | CASP1HSD17B10LOXLOXL2SORT1 | |
| SCHEMBL29664648 | 0.92 | LOX (0.38) | CASP1HSD17B10LOXLOXL2SORT1 | |
| SCHEMBL23215087 | 0.78 | LOX (0.41) | LOXLOXL2SORT1AAK1GABRA1 | |
| SCHEMBL29664670 | 0.78 | LOX (0.41) | LOXLOXL2SORT1AAK1GABRA1 | |
| SCHEMBL23215152 | 0.77 | LOX (0.45) | LOXLOXL2SORT1AAK1GABRA1 | |
| SCHEMBL29664692 | 0.77 | LOX (0.45) | LOXLOXL2SORT1AAK1GABRA1 | |
| SCHEMBL29664623 | 0.77 | FFAR1 (0.48) | LOXLOXL2SORT1CYP3A4FFAR1 | |
| SCHEMBL23216720 | 0.77 | FFAR1 (0.48) | LOXLOXL2SORT1CYP3A4FFAR1 | |
| SCHEMBL31121348 | 0.74 | NOS3 (0.52) | LOXLOXL2SORT1AAK1GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250171455-A1 | MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS | CONTINEUM THERAPEUTICS INC (US) | 2025-05-29 | — | — | US | disclosed |
| EP-4322951-A1 | CRYSTALLINE COMPOUND OF MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS | Pipeline Therapeutics, Inc. (US) | 2024-02-21 | — | — | EP | disclosed |
| CN-117479941-A | Crystalline compounds of muscarinic acetylcholine M1 receptor antagonists | 帕珀莱恩医疗公司 | 2024-01-30 | — | — | CN | disclosed |
| WO-2022221450-A1 | CRYSTALLINE COMPOUND OF MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS | Pipeline Therapeutics, Inc. (US) | 2022-10-20 | — | — | WO | disclosed |
| CN-114729044-A | Muscarinic acetylcholine M1Receptor antagonists | 帕珀莱恩医疗公司 | 2022-07-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171455-A1 | MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS | CHRM1, CHRM2, CHRM3 | CASP1 4215/4885HSD17B10 2834/4885LOX 1331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.